HCA Healthcare, Inc. $HCA Shares Sold by Leuthold Group LLC

Leuthold Group LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,606 shares of the company’s stock after selling 2,246 shares during the period. Leuthold Group LLC’s holdings in HCA Healthcare were worth $5,979,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the stock. Dixon Mitchell Investment Counsel Inc. raised its holdings in shares of HCA Healthcare by 6.9% in the second quarter. Dixon Mitchell Investment Counsel Inc. now owns 71,843 shares of the company’s stock worth $27,558,000 after acquiring an additional 4,625 shares during the last quarter. West Family Investments Inc. acquired a new position in HCA Healthcare in the 2nd quarter valued at about $235,000. Schroder Investment Management Group raised its position in shares of HCA Healthcare by 1.9% in the second quarter. Schroder Investment Management Group now owns 676,225 shares of the company’s stock valued at $259,062,000 after buying an additional 12,515 shares during the last quarter. F m Investments LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at $4,083,000. Finally, Norges Bank acquired a new position in HCA Healthcare in the second quarter valued at $1,152,408,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Down 0.4%

HCA opened at $512.94 on Friday. The firm has a market capitalization of $117.05 billion, a P/E ratio of 19.83, a P/E/G ratio of 1.38 and a beta of 1.41. The firm’s 50 day moving average is $452.07 and its 200-day moving average is $406.38. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $520.00.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same period in the prior year, the company posted $4.90 EPS. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Oppenheimer raised their target price on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Jefferies Financial Group boosted their price objective on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research note on Tuesday, October 28th. UBS Group lifted their target price on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a report on Monday, October 27th. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a report on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $474.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.